Total Payments
$4,230
2024 Payments
$1,324
Companies
36
Transactions
99
Medicare Patients
7,447
Medicare Billing
$237,258
Payment Breakdown by Category
Food & Beverage$3,971 (93.9%)
Education$258.76 (6.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,971 | 96 | 93.9% |
| Education | $258.76 | 3 | 6.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $358.79 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $322.33 | 4 | $0 (2024) |
| Puma Biotechnology, Inc. | $320.50 | 3 | $0 (2023) |
| Myriad Genetic Laboratories, Inc. | $315.85 | 5 | $0 (2024) |
| Gilead Sciences, Inc. | $250.07 | 4 | $0 (2024) |
| Incyte Corporation | $184.62 | 4 | $0 (2024) |
| Seagen Inc. | $174.25 | 3 | $0 (2023) |
| Lilly USA, LLC | $171.74 | 5 | $0 (2024) |
| ABBVIE INC. | $166.71 | 4 | $0 (2024) |
| Janssen Biotech, Inc. | $151.18 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,324 | 34 | Lilly USA, LLC ($171.74) |
| 2023 | $882.07 | 17 | SOBI, INC ($119.05) |
| 2022 | $965.15 | 21 | E.R. Squibb & Sons, L.L.C. ($249.39) |
| 2021 | $1,059 | 27 | Daiichi Sankyo Inc. ($256.59) |
All Payment Transactions
99 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.11 | General |
| Category: Hematology | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Oncology | ||||||
| 12/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: Oncology | ||||||
| 11/22/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | PFIZER INC. | IBRANCE (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $23.77 | General |
| Category: ONCOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/29/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Oncology | ||||||
| 10/22/2024 | Kite Pharma, Inc. | Yescarta (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: CELLT | ||||||
| 10/21/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $14.89 | General |
| Category: Hematology/Oncology | ||||||
| 10/10/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $111.06 | General |
| Category: Oncology | ||||||
| 09/26/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $101.18 | General |
| Category: ONC | ||||||
| 09/26/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $26.89 | General |
| Category: Hematology/Oncology | ||||||
| 09/24/2024 | Lilly USA, LLC | — | Education | In-kind items and services | $59.77 | General |
| 09/24/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.91 | General |
| 09/17/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/10/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $16.87 | General |
| Category: Hematology | ||||||
| 09/03/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $65.21 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | In-kind items and services | $111.46 | General |
| Category: Oncology / Rare Diseases | ||||||
| 07/18/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: ONCOLOGY | ||||||
| 07/16/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 2,308 | 3,384 | $331,491 | $70,727 |
| 2022 | 15 | 1,901 | 3,111 | $301,929 | $62,374 |
| 2021 | 14 | 1,695 | 2,626 | $276,650 | $60,027 |
| 2020 | 15 | 1,543 | 1,992 | $241,788 | $44,130 |
Total Patients
7,447
Total Services
11,113
Medicare Billing
$237,258
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 379 | 436 | $109,000 | $21,915 | 20.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 103 | 138 | $68,448 | $15,000 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 125 | $46,000 | $9,696 | 21.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 365 | 629 | $12,580 | $5,273 | 41.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 351 | 503 | $32,192 | $5,178 | 16.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 371 | 668 | $24,048 | $5,061 | 21.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 123 | 168 | $10,080 | $2,218 | 22.0% |
| 85055 | Reticulated (young) platelet measurement | Office | 2023 | 30 | 58 | $8,294 | $2,003 | 24.2% |
| 83550 | Iron binding capacity | Office | 2023 | 122 | 167 | $5,845 | $1,431 | 24.5% |
| 83540 | Iron level | Office | 2023 | 122 | 167 | $4,509 | $1,059 | 23.5% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 113 | 135 | $4,185 | $799.20 | 19.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 41 | 50 | $2,450 | $406.21 | 16.6% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 29 | 60 | $2,040 | $380.40 | 18.6% |
| 85007 | Microscopic examination for white blood cells with manual cell count | Office | 2023 | 29 | 60 | $1,320 | $219.48 | 16.6% |
| 84550 | Uric acid level, blood | Office | 2023 | 14 | 20 | $500.00 | $88.60 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 370 | 518 | $129,500 | $27,474 | 21.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 80 | 97 | $48,112 | $10,541 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 69 | 83 | $30,544 | $6,392 | 20.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 307 | 639 | $23,004 | $4,894 | 21.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 254 | 385 | $24,640 | $4,005 | 16.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 297 | 578 | $11,560 | $1,707 | 14.8% |
| 82728 | Ferritin (blood protein) level | Office | 2022 | 82 | 122 | $7,320 | $1,643 | 22.5% |
| 85055 | Reticulated (young) platelet measurement | Office | 2022 | 22 | 37 | $5,291 | $1,306 | 24.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 91 | 129 | $6,321 | $1,078 | 17.1% |
| 83550 | Iron binding capacity | Office | 2022 | 81 | 121 | $4,235 | $1,045 | 24.7% |
About Melissa Rodriguez
Melissa Rodriguez is a Family healthcare provider based in Denton, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2015. The National Provider Identifier (NPI) number assigned to this provider is 1063898922.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Rodriguez has received a total of $4,230 in payments from pharmaceutical and medical device companies, with $1,324 received in 2024. These payments were reported across 99 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,971).
As a Medicare-enrolled provider, Rodriguez has provided services to 7,447 Medicare beneficiaries, totaling 11,113 services with total Medicare billing of $237,258. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Denton, TX
- Active Since 08/03/2015
- Last Updated 10/02/2017
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1063898922
Products in Payments
- Enhertu (Drug) $322.12
- Trodelvy (Drug) $250.07
- NERLYNX (Drug) $233.15
- OPDIVO (Biological) $197.93
- myRisk (Device) $174.73
- JAKAFI (Drug) $165.86
- IMBRUVICA (Drug) $162.56
- ADCETRIS (Biological) $151.36
- LIBTAYO (Biological) $121.10
- Doptelet (Drug) $119.05
- XPOVIO (Drug) $117.92
- AYVAKIT (Drug) $111.46
- BESREMI (Drug) $111.06
- IMFINZI (Biological) $102.60
- LATUDA (Drug) $85.48
- OJJAARA (Drug) $72.40
- ZEJULA (Drug) $67.56
- MYRISK (Device) $65.21
- DARZALEX (Drug) $64.57
- VERZENIO (Drug) $64.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Denton
Ms. Christina Keil, Np, NP
Family — Payments: $4,642
Family $4,642
Karen Dodge, Np, NP
Family — Payments: $4,407
Family $4,407
Mrs. Jennifer Kamp, Fnp-C, FNP-C
Family — Payments: $4,326
Family $4,326
Jennifer Nuspel, F.n.p, F.N.P
Family — Payments: $3,088
Family $3,088
Brandi Clokey, Fnp-C, FNP-C
Family — Payments: $2,843
Family $2,843
Jisha Chacko, Rn, Msn, Np-C, RN, MSN, NP-C
Family — Payments: $2,392
Family $2,392